Cellid and Jig.jp Jointly Develop AR Glasses

Cellid and Jig.jp Jointly Develop AR Glasses

A Breakthrough in Everyday AR Glasses, delivered through Sabae Design, Japan's Only Optical Technology, and Software UX Innovation TOKYO, Dec. 11, 2025 /PRNewswire/ -- Cellid Inc., a developer of displays and spatial recognition engines for...

Locksley Commences Engineering Partner Selection Process for Its Desert Antimony Mine

Locksley Commences Engineering Partner Selection Process for Its Desert Antimony Mine

SAN BERNARDINO, Calif., Dec. 11, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQX: LKYRF) announced the company has formally commenced the engineering partner selection process for the upcoming engineering scoping pilot plant design,...

Massimo Group to Debut New MVR HVAC Pro Series at the 2026 PGA Show in Orlando, Featuring Fully Enclosed, Climate-Controlled Electric Vehicles

Massimo Group to Debut New MVR HVAC Pro Series at the 2026 PGA Show in Orlando, Featuring Fully Enclosed, Climate-Controlled Electric Vehicles

GARLAND, Texas, Dec. 11, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports and electric vehicles, announced today that it will debut its new MVR HVAC Pro Series at the 2026 PGA Show in Orlando, Florida....

ProPharma Expands Operations with New Office in Hyderabad

ProPharma Expands Operations with New Office in Hyderabad

Modern workspace supports continued growth and innovation RALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ -- ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of...

O-RAN Global PlugFest Fall 2025 Showcased Continued Evolution of Advanced Use Cases and Scenarios Featuring AI in the RAN

O-RAN Global PlugFest Fall 2025 Showcased Continued Evolution of Advanced Use Cases and Scenarios Featuring AI in the RAN

O-RAN ALLIANCE PlugFests offer collaborative environment to accelerate the development of open and intelligent RAN-based solutions The O-RAN Global PlugFest Fall 2025 showcased advances in automation, network optimization, energy efficiency, and...

MATELASER W1 REGEN: The Lightest 24g and Highest 5,100 mW/cm² Wearable Red Light Therapy Device Debuts on Kickstarter

MATELASER W1 REGEN: The Lightest 24g and Highest 5,100 mW/cm² Wearable Red Light Therapy Device Debuts on Kickstarter

MIAMI, Dec. 11, 2025 /PRNewswire/ -- MATELASER, INC., a pioneer in mobile laser therapy, today announced the official launch of its global crowdfunding campaign for the W1 REGEN, a breakthrough device that brings clinic-grade laser therapy into an...

HLB and So Ban Hang Launch Initiative to Simplify Business Management for Vietnamese mSMEs

HLB and So Ban Hang Launch Initiative to Simplify Business Management for Vietnamese mSMEs

HO CHI MINH CITY, Vietnam, Dec. 11, 2025 /PRNewswire/ -- Hong Leong Bank Vietnam ("HLB" or the "Bank"), following its strategic partnership with So Ban Hang, has launched a new initiative to assist Vietnamese entrepreneurs and micro, small, and...

Yiren Digital Wins "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards

Yiren Digital Wins "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards

BEIJING, Dec. 11, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading Fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and Southeast...

Smart Energy in Action: JA Solar's first BESS for C&I in Sicily, Italy

Smart Energy in Action: JA Solar's first BESS for C&I in Sicily, Italy

PALERMO, Italy, Dec. 11, 2025 /PRNewswire/ -- JA Solar, a global leader in photovoltaic products and integrated energy solutions, announced the successful commissioning of a solar-plus-storage microgrid at a modern C&I facility in Sicily. This...

NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO

NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care,...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 199
  • menu
    menu